Abstract:To investigate the effect of recombinant human growth hormone (r-hGH) combined with dehydroepiandrosterone (DHEA) on the ovarian hyporesponsive mouse model and its effect on the expression ofgrowth differentiation factor-9 (GDF-9), advanced glycation end product (AGE) and receptor of advanced glycation endproducts (RAGE). Methods100 mice were randomly divided into control group, model group, r-hGH group, DHEA group and r-hGH+DHEA group. A model of premature ovarian failure and ovarian hyporesponsiveness was established using chronic brake stress. The control group was treated with the same amount of solvent. The r-hGH group and DHEA group were treated with r-hGH and DHEA respectively. The mice in the r-hGH+DHEA group were treated with r-hGH and DHEA. The level of anti-Mullerian hormone (AMH) in the serum was measured. The number of follicles in the ovary was measured using HE staining. qRT-PCR and Western blotting were used to detect the levels of AGE, RAGE GDF-9 mRNA and protein in follicles in ovarian tissue. ResultsAfter modeling, mouse serum AMH, follicle number, AGE, RAGE and GDF-9 mRNA and protein levels were significantly reduced (P<0.05). The AMH, follicle number, AGE, RAGE, and GDF-9 mRNA and protein levelsin the r-hGH group and DHEA group were significantly higher than those in the model group (P<0.05). The AMH, follicle number, AGE, RAGE, and GDF-9 mRNA and protein levels in the r-hGH+DHEA group were significantly higher than those in the r-hGH and DHEA groups (P<0.05). ConclusionR-hGH combined with DHEA has a good intervention effect on POR mouse model, which may be related to its down-regulation of AGE and RAGE mRNA levels in ovary and promotion of GDF-9 expression.